Total Payments
$6,094
2024 Payments
$325.23
Companies
17
Transactions
49
Medicare Patients
5,001
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$5,054 (82.9%)
Food & Beverage$1,033 (17.0%)
Education$6.80 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,054 | 4 | 82.9% |
| Food and Beverage | $1,033 | 44 | 17.0% |
| Education | $6.80 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $5,498 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $92.03 | 6 | $0 (2024) |
| LeMaitre Vascular, Inc. | $90.95 | 1 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $74.80 | 4 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $73.54 | 1 | $0 (2021) |
| Vifor Pharma, Inc. | $50.15 | 3 | $0 (2024) |
| Ardelyx, Inc. | $33.10 | 2 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $27.18 | 2 | $0 (2018) |
| Relypsa, Inc. | $26.44 | 2 | $0 (2018) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $24.94 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $325.23 | 15 | AstraZeneca Pharmaceuticals LP ($92.03) |
| 2023 | $5,364 | 16 | Bayer Healthcare Pharmaceuticals Inc. ($5,301) |
| 2022 | $157.27 | 5 | Bayer HealthCare Pharmaceuticals Inc. ($123.33) |
| 2021 | $87.51 | 2 | Bard Peripheral Vascular, Inc. ($73.54) |
| 2019 | $28.88 | 2 | Fresenius USA Marketing, Inc. ($14.68) |
| 2018 | $61.71 | 5 | OPKO Pharmaceuticals, LLC ($27.18) |
| 2017 | $69.50 | 4 | Fresenius USA Marketing, Inc. ($22.47) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | LeMaitre Vascular, Inc. | ARTEGRAFT VASCULAR GRAFT (Device) | Food and Beverage | Cash or cash equivalent | $90.95 | General |
| Category: ARTEGRAFT | ||||||
| 09/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardio-renal | ||||||
| 09/04/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Hyperkalemia | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Cardio-renal | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Cardio-renal | ||||||
| 12/06/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Nephrology | ||||||
| 12/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardio-renal | ||||||
| 10/19/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Hyperkalemia | ||||||
| 10/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,805.00 | General |
| Category: Cardio-renal | ||||||
| 10/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $39.01 | General |
| Category: Cardio-renal | ||||||
| 10/05/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $13.07 | General |
| 10/04/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardio-renal | ||||||
| 10/03/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $9.83 | General |
| 08/08/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,166.00 | General |
| Category: Cardio-renal | ||||||
| 08/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $120.49 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,366 | 2,630 | $695,839 | $292,802 |
| 2022 | 17 | 1,151 | 2,118 | $564,600 | $235,678 |
| 2021 | 12 | 1,006 | 1,966 | $564,970 | $250,808 |
| 2020 | 20 | 1,478 | 2,878 | $909,806 | $328,344 |
Total Patients
5,001
Total Services
9,592
Medicare Billing
$1.1M
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 37 | 273 | $204,750 | $79,330 | 38.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 180 | 377 | $64,090 | $36,558 | 57.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 212 | 548 | $71,240 | $35,837 | 50.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 171 | 318 | $87,450 | $28,737 | 32.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 131 | 145 | $50,750 | $19,651 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 208 | $41,600 | $19,185 | 46.1% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2023 | 67 | 213 | $48,990 | $17,992 | 36.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 58 | 58 | $17,400 | $9,607 | 55.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 22 | 36 | $27,000 | $8,648 | 32.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 26 | $13,000 | $5,499 | 42.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 41 | 86 | $13,760 | $5,106 | 37.1% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 59 | 100 | $10,000 | $5,104 | 51.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 49 | 59 | $8,850 | $5,016 | 56.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 27 | 27 | $8,505 | $3,856 | 45.3% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 26 | 30 | $6,600 | $3,790 | 57.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 45 | $6,300 | $2,787 | 44.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 15 | $7,500 | $2,656 | 35.4% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 19 | 19 | $4,655 | $2,118 | 45.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 19 | 20 | $2,400 | $998.07 | 41.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 27 | $999.00 | $327.51 | 32.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 31 | 217 | $162,750 | $64,654 | 39.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 185 | 392 | $66,640 | $33,421 | 50.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 200 | 466 | $60,580 | $27,839 | 46.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 146 | 239 | $65,725 | $21,712 | 33.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 118 | 128 | $44,800 | $20,580 | 45.9% |
About Dr. Robert Mathews, MD
Dr. Robert Mathews, MD is a Internal Medicine healthcare provider based in Northfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1902060221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Mathews, MD has received a total of $6,094 in payments from pharmaceutical and medical device companies, with $325.23 received in 2024. These payments were reported across 49 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,054).
As a Medicare-enrolled provider, Mathews has provided services to 5,001 Medicare beneficiaries, totaling 9,592 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Northfield, NJ
- Active Since 07/16/2008
- Last Updated 02/27/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902060221
Products in Payments
- Kerendia (Drug) $5,498
- FARXIGA (Drug) $92.03
- ARTEGRAFT VASCULAR GRAFT (Device) $90.95
- Veltassa (Drug) $76.59
- COVERA (Device) $73.54
- Velphoro (Drug) $52.33
- IBSRELA (Drug) $33.10
- Rayaldee (Drug) $27.18
- Dialyzers (Device) $22.47
- TARPEYO (Drug) $22.08
- RENVELA (Drug) $18.21
- AURYXIA (Drug) $14.20
- Viekira (Drug) $13.89
- JARDIANCE (Drug) $13.29
- JYNARQUE (Drug) $11.87
- INJECTAFER (Drug) $11.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Northfield
Samuel Moltz, M.d, M.D
Internal Medicine — Payments: $43,115
Internal Medicine $43,115
Dr. Ulices Perez Feliz, Md, MD
Internal Medicine — Payments: $5,482
Internal Medicine $5,482
Dr. Steven Wolfman, D.o, D.O
Internal Medicine — Payments: $3,169
Internal Medicine $3,169
Maria Jimenez Cerna, M.d, M.D
Internal Medicine — Payments: $2,311
Internal Medicine $2,311
Dr. Nitin Behl, M.d, M.D
Internal Medicine — Payments: $781.28
Internal Medicine $781.28
Behdokht Daneshvar, Md, MD
Internal Medicine — Payments: $645.12
Internal Medicine $645.12